Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1985 1
1998 1
2000 1
2002 1
2004 2
2005 1
2006 4
2007 1
2010 6
2011 2
2012 7
2013 4
2014 2
2015 4
2016 2
2017 2
2018 2
2019 1
2020 4
2021 4
2022 7
2023 4
2024 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

60 results

Results by year

Filters applied: . Clear all
Page 1
Improved Outcomes With Retinoic Acid and Arsenic Trioxide Compared With Retinoic Acid and Chemotherapy in Non-High-Risk Acute Promyelocytic Leukemia: Final Results of the Randomized Italian-German APL0406 Trial.
Platzbecker U, Avvisati G, Cicconi L, Thiede C, Paoloni F, Vignetti M, Ferrara F, Divona M, Albano F, Efficace F, Fazi P, Sborgia M, Di Bona E, Breccia M, Borlenghi E, Cairoli R, Rambaldi A, Melillo L, La Nasa G, Fiedler W, Brossart P, Hertenstein B, Salih HR, Wattad M, Lübbert M, Brandts CH, Hänel M, Röllig C, Schmitz N, Link H, Frairia C, Pogliani EM, Fozza C, D'Arco AM, Di Renzo N, Cortelezzi A, Fabbiano F, Döhner K, Ganser A, Döhner H, Amadori S, Mandelli F, Ehninger G, Schlenk RF, Lo-Coco F. Platzbecker U, et al. Among authors: d arco am. J Clin Oncol. 2017 Feb 20;35(6):605-612. doi: 10.1200/JCO.2016.67.1982. Epub 2016 Oct 31. J Clin Oncol. 2017. PMID: 27400939 Free article. Clinical Trial.
Fluorouracil and dose-dense adjuvant chemotherapy in patients with early-stage breast cancer (GIM2): end-of-study results from a randomised, phase 3 trial.
Del Mastro L, Poggio F, Blondeaux E, De Placido S, Giuliano M, Forestieri V, De Laurentiis M, Gravina A, Bisagni G, Rimanti A, Turletti A, Nisticò C, Vaccaro A, Cognetti F, Fabi A, Gasparro S, Garrone O, Alicicco MG, Urracci Y, Mansutti M, Poletti P, Correale P, Bighin C, Puglisi F, Montemurro F, Colantuoni G, Lambertini M, Boni L; Gruppo Italiano Mammella Investigators. Del Mastro L, et al. Lancet Oncol. 2022 Dec;23(12):1571-1582. doi: 10.1016/S1470-2045(22)00632-5. Epub 2022 Nov 10. Lancet Oncol. 2022. PMID: 36370716 Clinical Trial.
Extraordinary optical transmittance generation on Si3N4 membranes.
Macis S, Paolozzi MC, D'Arco A, Piccirilli F, Stopponi V, Rossi M, Moia F, Toma A, Lupi S. Macis S, et al. Among authors: d arco a. Nanoscale. 2023 Oct 12;15(39):16002-16009. doi: 10.1039/d3nr02834h. Nanoscale. 2023. PMID: 37779505 Free PMC article.
Terahertz and Infrared Plasmon Polaritons in PtTe2 Type-II Dirac Topological Semimetal.
Macis S, D'Arco A, Mosesso L, Paolozzi MC, Tofani S, Tomarchio L, Tummala PP, Ghomi S, Stopponi V, Bonaventura E, Massetti C, Codegoni D, Serafini A, Targa P, Zacchigna M, Lamperti A, Martella C, Molle A, Lupi S. Macis S, et al. Among authors: d arco a. Adv Mater. 2024 Jul;36(29):e2400554. doi: 10.1002/adma.202400554. Epub 2024 May 22. Adv Mater. 2024. PMID: 38733453
60 results